Researchers found that a new oral medication called Foundayo (orforglipron) can help older adults lose significant weight. In a recent analysis of clinical trials, adults aged 65 and older with obesity or overweight lost up to 13% of their body weight after taking the drug for 72 weeks. This weight loss was achieved without the need for food or water restrictions, making it a convenient option for many.

For older adults looking to manage their weight, this finding is particularly important. Maintaining a healthy weight can improve overall health by reducing the risk of conditions like heart disease, diabetes, and joint problems. In the trials, those taking the highest dose of Foundayo lost an average of 13% of their body weight, compared to just 1.6% in the placebo group. This suggests that Foundayo could be an effective tool for older adults struggling with weight management.

The evidence comes from two large Phase 3 trials that included over 4,700 participants, with a notable number aged 65 and older. While the results are promising, they should be interpreted cautiously as they are based on post-hoc analyses, meaning they were not the primary focus of the original studies. More dedicated research is needed to confirm these findings and understand the long-term effects of the medication.

If you’re considering weight management options, it may be worth discussing Foundayo with your healthcare provider, especially if you are over 65 and have struggled with weight issues. They can provide guidance on whether this medication might be appropriate for you, taking into account your overall health and any other medications you may be taking.

Source: investor.lilly.com